10 | $ADDYY News Article - Adidas Boosts Outlook On | whytestocks | 04/17/2024 11:00:52 AM |
9 | $ADDYY News Article - Snap Teams up with Adidas | whytestocks | 10/09/2019 10:55:41 AM |
8 | ADDYY Financials 07/15/2014 21:29:31 adidas AG | Emylers | 07/15/2014 10:29:29 PM |
7 | Latest Adidas Ag (ADDYY) Headlines Goals Galore | Stock_Tracker | 03/08/2014 4:55:31 PM |
6 | ADDYY 55.98 Stock Charts $ADDYY 1 Month Chart | chartguy89 | 03/05/2014 6:33:29 PM |
5 | ADDYY Recent News Business events scheduled for | Stock_Tracker | 03/02/2014 2:00:37 AM |
4 | ADDYY Stock Charts Saturday, February 22, 2014 at | chartguy89 | 02/22/2014 1:51:19 AM |
3 | ADDYY Stock Chart 58.23 Saturday, February 8, | chartguy89 | 02/08/2014 12:54:19 AM |
2 | solid global, | wippersnapper | 12/14/2012 1:28:23 PM |
1 | All Day I Dream About Stocks!! | wippersnapper | 12/14/2012 1:27:27 PM |
Recent Articles
- Critical Updates for Reckitt Benckiser Group PLC Investors
- Investors Outcry: Join the Lockheed Martin Securities Class Action
- Investors Take Action: Join the Sable Offshore Securities Case
- Slate Truck: Budget-Friendly EV Picks Up Speed with New Model
- Kiyosaki on Trump's Cryptocurrency Vision for America
- Robert Kiyosaki on Trump's Vision for Crypto Dominance
- Stock Stars of the Week: Insights into Recent Gains
- Take Action If You've Lost Over $100K in 3D Systems
- Updates on Class Action Suit Against Novo Nordisk Investors
- Bitcoin Swift's Stage 3 Presale: Unprecedented Yield Opportunities
- Join the Class Action Against PepGen Securities Fraud Now
- Sarepta Investors Encouraged to Join Legal Action for Justice
- Hangzhou Strengthens Global Connections Through Cultural Ties
- Investors Encouraged to Join Rocket Pharmaceuticals Class Action
- Market Insights: Declining Large Caps and Financial Impacts
- Opportunity for Investors Affected by Petco Securities Fraud
- Investors Can Lead 3D Systems Securities Fraud Class Action
- Investors Urged to Join Alto Neuroscience Securities Lawsuit
- Investors Urged to Join Lawsuit Against Vestis Corporation Today
- Important Legal Updates for PepGen Inc. Investors Ahead
- Investors Have a Unique Chance to Lead Fiserv's Securities Case
- Investors Encouraged to Join the Centene Securities Fraud Case
- HashJ Unveils User-Friendly XRP Contracts Amid Market Surge
- Tech Giants' Earnings Insight Amid Economic Concerns
- Investors Can Lead Legal Action Against Hims Securities Fraud
- Investors Can Take Action in the iRobot Class Action Suit
- J.M. Smucker Co. Under Scrutiny: Investment Concerns Arise
- Hims & Hers Legal Situation: Understanding Your Options
- Sarepta Therapeutics Faces Legal Challenges Over Elevidys Risks
- Legal Considerations for RxSight, Inc. Investors Amidst Stock Decline
- Michael Owen Partners with GK8 for iGaming Expansion Success
- HashJ Expands Accessibility for XRP Investors with New Contracts
- Trice Contracting Inc. Expands Services for Historic Preservation
- Revolutionary Weight Loss Pill Offers New Hope for Obesity
- Exploring the Future of Internet Connectivity with Starlink
- Seize the Moment: Participate in Reckitt Benckiser Class Action
- Reckitt Benckiser Securities Fraud Lawsuit Deadline Approaches
- Therapy Ideas for Your Innovative Health and Wellness Center
- Meta's Bold Move: Why Investing $250M in AI Talent Matters
- Accessory Dwelling Unit Plans in 2025: Smart Designs for Purpose, Space & Long-Term Value
- Impact of Tariff Loophole Elimination on Global Commerce
- Berkshire Hathaway's $3.8 Billion Write-Down on Kraft Heinz
- Unveiling Success: President Trump's Achievements This Week
- Berkshire Hathaway's Caution as Cash Reserves Hit $344 Billion
- Elon Musk Addresses Control Concerns Amid Shareholder Influence
- Unlocking Fitness Franchise Opportunities: Your Guide to a Stronger Business Future
- President Trump’s Vision: Turning America’s Aspirations into Reality
- Home Sellers Adjust to Buyer Hesitation Amid Price Challenges
- Two Smart Paths to Franchise Ownership: Medical and Mosquito Control Businesses
- Investor Alert: Class Actions for Neogen, Alto, RxSight, and Replimune